28 Stocks Moving in Thursday's Pre-Market Session

This post was originally published on this site

© Provided by Benzinga

Gainers

Galera Therapeutics, Inc. (NASDAQ: GRTX) rose 39.6% to $9.23 in pre-market trading after the company disclosed updated data from its randomized, multicenter, placebo-controlled trial in patients with pancreatic cancer. Willamette Valley Vineyards, Inc. (NASDAQ: WVVI) rose 20.1% to $12.30 in pre-market trading. Uxin Limited (NASDAQ: UXIN) rose 17.6% to $3.47 in pre-market trading. Uxin shares jumped 45% on Wednesday after the company reported Q3 earnings results. Nokia Corporation (NYSE: NOK) shares rose 15.5% to $4.85 in pre-market trading after reporting upbeat Q1 results. Evolve Transition Infrastructure LP (NYSE: SNMP) rose 13.9% to $0.91 in pre-market trading. Evolve Transition, last month, reported FY20 sales of $57 million. Hall of Fame Resort & Entertainment Company (NASDAQ: HOFV) rose 9.7% to $4.31 in pre-market trading. JAKKS Pacific, Inc. (NASDAQ: JAKK) rose 9.1% to $8.00 in pre-market trading after the company reported better-than-expected Q1 results. Akebia Therapeutics, Inc. (NASDAQ: AKBA) rose 8.4% to $3.47 in pre-market trading after the company highlighted New England Journal of Medicine published results of global Phase 3 program of Vadadustat for the treatment of anemia due to chronic kidney disease. Cheesecake Factory Inc (NASDAQ: CAKE) rose 8.2% to $63.88 in pre-market trading after reporting higher quarterly earnings. Galectin Therapeutics Inc. (NASDAQ: GALT) shares rose 7.7% to $5.49 in pre-market trading after jumping over 22% on Wednesday. The company recently announced neurosurgeon Dr. Ben Carson, Sr. joined the team as a special consultant to accelerate and enhance development of the company’s galectin-3 inhibitor, belapectin. Ashford Hospitality Trust, Inc. (NYSE: AHT) rose 7.6% to $2.68 in pre-market trading after surging around 32% on Wednesday. Facebook, Inc. (NASDAQ: FB) rose 7.2% to $329.09 in pre-market trading after the company reported upbeat results for its first quarter on Wednesday. The company reported 1.88 billion daily active users, up 8% year-over-year, as well as 2.85 billion monthly active users, up 10% year-over-year. Novo Integrated Sciences, Inc. (NASDAQ: NVOS) shares rose 7.1% to $2.85 in pre-market trading after declining over 13% on Wednesday. The company recently reported Q2 revenue of $2.08 million. Osmotica Pharmaceuticals plc (NASDAQ: OSMT) rose 7.1% to $3.18 in pre-market trading. Tuscan Holdings Corp. (NASDAQ: THCB) shares rose 6.7% to $12.26 in pre-market trading. Tuscan said it has adjourned its annual meeting of stockholders to May 10th to allow more time to vote on the extension amendment proposal. Super League Gaming, Inc. (NASDAQ: SLGG) rose 6.3% to $5.87 in pre-market trading. QUALCOMM Incorporated (NASDAQ: QCOM) rose 5.1% to $143.46 in pre-market trading after the company reported better-than-expected Q2 results and issued strong Q3 EPS guidance. Align Technology, Inc. (NASDAQ: ALGN) shares rose 4.3% to $640.00 in pre-market trading after the company reported better-than-expected Q1 results and issued FY21 revenue guidance above estimates. Apple Inc. (NASDAQ: AAPL) rose 2.8% to $137.35 in pre-market trading after the company reported better-than-expected Q2 results. The company also announced it added $90 billion to its buyback program.

Find out what’s going on in today’s market and bring any questions you have to Benzinga’s PreMarket Prep.

Load Error

Check out these big penny stock gainers and losers

Losers

Farmmi, Inc. (NASDAQ: FAMI) fell 54.7% to $0.358 in pre-market trading after the company priced its $42.0 million upsized underwritten public offering of ordinary shares. Adverum Biotechnologies, Inc. (NASDAQ: ADVM) shares fell 43.9% to $5.70 in pre-market trading in reaction to a Suspected Unexpected Serious Adverse Reaction of hypotony (clinically-relevant decrease in ocular pressure). The event was reported in the INFINITY Phase 2 trial evaluating ADVM-022 gene therapy to treat diabetic macular edema. Tenaris S.A. (NYSE: TS) fell 7.3% to $21.01 in pre-market trading after the company reported Q1 results. Hologic, Inc. (NASDAQ: HOLX) fell 7% to $67.32 in pre-market trading after the company reported worse-than-expected Q2 results and issued weak Q3 guidance. Vyant Bio, Inc. (NASDAQ: VYNT) fell 6.5% to $4.35 in pre-market trading after climbing 16% on Wednesday. Vyant Bio, Ordaōs Bio and Cellaria, recently announced collaboration to ‘design and qualify biomarker-specific small protein therapeutics.’ ServiceNow, Inc. (NYSE: NOW) fell 6.3% to $521.89 in pre-market trading after the company reported Q1 earnings results. eBay Inc. (NASDAQ: EBAY) fell 5.7% to $58.80 in pre-market trading. eBay reported upbeat Q1 earnings, but issued weak earnings guidance for the current quarter. Teladoc Health, Inc. (NASDAQ: TDOC) fell 4.1% to $178.60 in pre-market trading after reporting Q1 results. Ford Motor Company (NYSE: F) fell 2.6% to $12.11 in pre-market trading after the company reported Q1 earnings results.

Continue Reading

Related Posts